Par Drugs and Chemicals Limited — Board Meeting, 10-02-2026: Outcome of Board Meeting
10-02-2026 | 05:26 pm
10-02-2026 | 05:26 pm
Par Drugs & Chemicals board approved financial results for the quarter and nine-month period. Q3 profit reached ₹4.80 Cr (EPS ₹3.90), while 9M profit hit ₹12.25 Cr (EPS ₹9.96). The board also evaluated independent directors and updated its related-party transactions policy.
No comments yet. Be the first to comment!
